← Insider buys
KITE

Kite Pharma, Inc.

Director Ran Nussbaum bought $679K of Kite Pharma, Inc.

Bought$679,474
$69.11Price
9,832Shares
−187%Stake

What KITE did for a copier

Prices for KITE after this filing aren't in yet.

Ran Nussbaum's record

7 other buys on record. A record shows here once 3 of them have 3 months of prices.

We're building an app that can copy buys like this into your own brokerage. Join the waitlist

Traded Tue, May 9. Filed Thu, May 11, 10:02 AM ET, during the session. Not investment advice.